Cancer Research Targets Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fang, M. Z.
Right arrow Articles by Yang, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fang, M. Z.
Right arrow Articles by Yang, C. S.
[Cancer Research 63, 7563-7570, November 15, 2003]
© 2003 American Association for Cancer Research

Advances in Brief

Tea Polyphenol (-)-Epigallocatechin-3-Gallate Inhibits DNA Methyltransferase and Reactivates Methylation-Silenced Genes in Cancer Cell Lines

Ming Zhu Fang1, Yimin Wang1, Ni Ai2, Zhe Hou1, Yi Sun1, Hong Lu1, William Welsh2 and Chung S. Yang1

1 Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey,
2 Department of Pharmacology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, New Jersey

Hypermethylation of CpG islands in the promoter regions is an important mechanism to silence the expression of many important genes in cancer. The hypermethylation status is passed to the daughter cells through the methylation of the newly synthesized DNA strand by 5-cytosine DNA methyltransferase (DNMT). We report herein that (-)-epigallocatechin-3-gallate (EGCG), the major polyphenol from green tea, can inhibit DNMT activity and reactivate methylation-silenced genes in cancer cells. With nuclear extracts as the enzyme source and polydeoxyinosine-deoxycytosine as the substrate, EGCG dose-dependently inhibited DNMT activity, showing competitive inhibition with a Ki of 6.89 µM. Studies with structural analogues of EGCG suggest the importance of D and B ring structures in the inhibitory activity. Molecular modeling studies also support this conclusion, and suggest that EGCG can form hydrogen bonds with Pro1223, Glu1265, Cys1225, Ser1229, and Arg1309 in the catalytic pocket of DNMT. Treatment of human esophageal cancer KYSE 510 cells with 5–50 µM of EGCG for 12–144 h caused a concentration- and time-dependent reversal of hypermethylation of p16INK4a, retinoic acid receptor ß (RARß), O6-methylguanine methyltransferase (MGMT), and human mutL homologue 1 (hMLH1) genes as determined by the appearance of the unmethylation-specific bands in PCR. This was accompanied by the expression of mRNA of these genes as determined by reverse transcription-PCR. The re-expression of RARß and hMLH1 proteins by EGCG was demonstrated by Western blot. Reactivation of some methylation-silenced genes by EGCG was also demonstrated in human colon cancer HT-29 cells, esophageal cancer KYSE 150 cells, and prostate cancer PC3 cells. The results demonstrate for the first time the inhibition of DNA methylation by a commonly consumed dietary constituent and suggest the potential use of EGCG for the prevention or reversal of related gene-silencing in the prevention of carcinogenesis.




This article has been cited by other articles:


Home page
 Anticancer ResHome page
Z. GAO, Z. XU, M.-S. HUNG, Y.-C. LIN, T. WANG, M. GONG, X. ZHI, D. M. JABLON, and L. YOU
Promoter Demethylation of WIF-1 by Epigallocatechin-3-gallate in Lung Cancer Cells
Anticancer Res, June 1, 2009; 29(6): 2025 - 2030.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
L. Ellis, P. W. Atadja, and R. W. Johnstone
Epigenetics in cancer: Targeting chromatin modifications
Mol. Cancer Ther., June 1, 2009; 8(6): 1409 - 1420.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Datta, K. Ghoshal, W. A. Denny, S. A. Gamage, D. G. Brooke, P. Phiasivongsa, S. Redkar, and S. T. Jacob
A New Class of Quinoline-Based DNA Hypomethylating Agents Reactivates Tumor Suppressor Genes by Blocking DNA Methyltransferase 1 Activity and Inducing Its Degradation
Cancer Res., May 15, 2009; 69(10): 4277 - 4285.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
Z. Liu, S. Liu, Z. Xie, R. E. Pavlovicz, J. Wu, P. Chen, J. Aimiuwu, J. Pang, D. Bhasin, P. Neviani, et al.
Modulation of DNA Methylation by a Sesquiterpene Lactone Parthenolide
J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 505 - 514.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Prevention ResearchHome page
S. Song, B. Guan, T. Men, A. Hoque, R. Lotan, and X.-C. Xu
Antitumor Effect of Retinoic Acid Receptor-{beta}2 Associated with Suppression of Cyclooxygenase-2
Cancer Prevention Research, March 1, 2009; 2(3): 274 - 280.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. W. Anderson, C. Goodin, Y. Zhang, S. Kim, R. D. Estensen, T. S. Wiedmann, P. Sekar, C. R. Buncher, J. C. Khoury, J. R. Garbow, et al.
Effect of dietary green tea extract and aerosolized difluoromethylornithine during lung tumor progression in A/J strain mice
Carcinogenesis, August 1, 2008; 29(8): 1594 - 1600.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
L. Fini, M. Selgrad, V. Fogliano, G. Graziani, M. Romano, E. Hotchkiss, Y. A. Daoud, E. B. De Vol, C. R. Boland, and L. Ricciardiello
Annurca Apple Polyphenols Have Potent Demethylating Activity and Can Reactivate Silenced Tumor Suppressor Genes in Colorectal Cancer Cells
J. Nutr., December 1, 2007; 137(12): 2622 - 2628.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
F. L. Martin
Epigenomics and disease, 10th anniversary winter meeting of the UK Molecular Epidemiology Group (MEG), The Royal Statistical Society, London, UK, 8th December 2006
Mutagenesis, November 1, 2007; 22(6): 425 - 427.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
E. P. Moiseeva, G. M. Almeida, G. D.D. Jones, and M. M. Manson
Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells
Mol. Cancer Ther., November 1, 2007; 6(11): 3071 - 3079.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
L. Kopelovich, J. R. Fay, C. C. Sigman, and J. A. Crowell
The Mammalian Target of Rapamycin Pathway as a Potential Target for Cancer Chemoprevention
Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1330 - 1340.
[Abstract] [Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
J. R. Carlson, B. A. Bauer, A. Vincent, P. J. Limburg, and T. Wilson
Reading the Tea Leaves: Anticarcinogenic Properties of (-)-Epigallocatechin-3-Gallate
Mayo Clin. Proc., June 1, 2007; 82(6): 725 - 732.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
M. Fang, D. Chen, and C. S. Yang
Dietary Polyphenols May Affect DNA Methylation
J. Nutr., January 1, 2007; 137(1): 223S - 228S.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
R. H. Dashwood
Frontiers in Polyphenols and Cancer Prevention
J. Nutr., January 1, 2007; 137(1): 267S - 269S.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
S. R. Morey, D. J. Smiraglia, S. R. James, J. Yu, M. T. Moser, B. A. Foster, and A. R. Karpf
DNA Methylation Pathway Alterations in an Autochthonous Murine Model of Prostate Cancer
Cancer Res., December 15, 2006; 66(24): 11659 - 11667.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
H. M. Abdolmaleky, K.-h. Cheng, S. V. Faraone, M. Wilcox, S. J. Glatt, F. Gao, C. L. Smith, R. Shafa, B. Aeali, J. Carnevale, et al.
Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder
Hum. Mol. Genet., November 1, 2006; 15(21): 3132 - 3145.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. A. Shammas, P. Neri, H. Koley, R. B. Batchu, R. C. Bertheau, V. Munshi, R. Prabhala, M. Fulciniti, Y. t. Tai, S. P. Treon, et al.
Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications
Blood, October 15, 2006; 108(8): 2804 - 2810.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Kuzuhara, Y. Sei, K. Yamaguchi, M. Suganuma, and H. Fujiki
DNA and RNA as New Binding Targets of Green Tea Catechins
J. Biol. Chem., June 23, 2006; 281(25): 17446 - 17456.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
M. D. Navarro-Martinez, F. Garcia-Canovas, and J. N. Rodriguez-Lopez
Tea polyphenol epigallocatechin-3-gallate inhibits ergosterol synthesis by disturbing folic acid metabolism in Candida albicans
J. Antimicrob. Chemother., June 1, 2006; 57(6): 1083 - 1092.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
B. R. Vuillemenot, J. A. Hutt, and S. A. Belinsky
Gene Promoter Hypermethylation in Mouse Lung Tumors
Mol. Cancer Res., April 1, 2006; 4(4): 267 - 273.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Stresemann, B. Brueckner, T. Musch, H. Stopper, and F. Lyko
Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines.
Cancer Res., March 1, 2006; 66(5): 2794 - 2800.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Lu, R. Yao, Y. Yan, Y. Wang, Y. Hara, R. A. Lubet, and M. You
A Gene Expression Signature that Can Predict Green Tea Exposure and Chemopreventive Efficacy of Lung Cancer in Mice
Cancer Res., February 15, 2006; 66(4): 1956 - 1963.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
W. J. Lee and B. T. Zhu
Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols
Carcinogenesis, February 1, 2006; 27(2): 269 - 277.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. T. McCabe, J. A. Low, S. Daignault, M. J. Imperiale, K. J. Wojno, and M. L. Day
Inhibition of DNA Methyltransferase Activity Prevents Tumorigenesis in a Mouse Model of Prostate Cancer
Cancer Res., January 1, 2006; 66(1): 385 - 392.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
F. Lyko and R. Brown
DNA Methyltransferase Inhibitors and the Development of Epigenetic Cancer Therapies
J Natl Cancer Inst, October 19, 2005; 97(20): 1498 - 1506.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
J. C. Chuang, C. B. Yoo, J. M. Kwan, T. W.H. Li, G. Liang, A. S. Yang, and P. A. Jones
Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine
Mol. Cancer Ther., October 1, 2005; 4(10): 1515 - 1520.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Z. Fang, D. Chen, Y. Sun, Z. Jin, J. K. Christman, and C. S. Yang
Reversal of Hypermethylation and Reactivation of p16INK4a, RAR{beta}, and MGMT Genes by Genistein and Other Isoflavones from Soy
Clin. Cancer Res., October 1, 2005; 11(19): 7033 - 7041.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
W. J. Lee, J.-Y. Shim, and B. T. Zhu
Mechanisms for the Inhibition of DNA Methyltransferases by Tea Catechins and Bioflavonoids
Mol. Pharmacol., October 1, 2005; 68(4): 1018 - 1030.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Z. Hou, S. Sang, H. You, M.-J. Lee, J. Hong, K.-V. Chin, and C. S. Yang
Mechanism of Action of (-)-Epigallocatechin-3-Gallate: Auto-oxidation-Dependent Inactivation of Epidermal Growth Factor Receptor and Direct Effects on Growth Inhibition in Human Esophageal Cancer KYSE 150 Cells
Cancer Res., September 1, 2005; 65(17): 8049 - 8056.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. A. Belinsky
Silencing of genes by promoter hypermethylation: key event in rodent and human lung cancer
Carcinogenesis, September 1, 2005; 26(9): 1481 - 1487.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. Kim, A. Murakami, K. Kawabata, and H. Ohigashi
(-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells
Carcinogenesis, September 1, 2005; 26(9): 1553 - 1562.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. Brueckner, R. Garcia Boy, P. Siedlecki, T. Musch, H. C. Kliem, P. Zielenkiewicz, S. Suhai, M. Wiessler, and F. Lyko
Epigenetic Reactivation of Tumor Suppressor Genes by a Novel Small-Molecule Inhibitor of Human DNA Methyltransferases
Cancer Res., July 15, 2005; 65(14): 6305 - 6311.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
M. Fenech
The Genome Health Clinic and Genome Health Nutrigenomics concepts: diagnosis and nutritional treatment of genome and epigenome damage on an individual basis
Mutagenesis, July 1, 2005; 20(4): 255 - 269.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
K. Miyamoto and T. Ushijima
Diagnostic and Therapeutic Applications of Epigenetics
Jpn. J. Clin. Oncol., June 1, 2005; 35(6): 293 - 301.
[Abstract] [Full Text] [PDF]

Home page
 ANN BOT (LOND)Home page
J. W. FINLEY
Proposed Criteria for Assessing the Efficacy of Cancer Reduction by Plant Foods Enriched in Carotenoids, Glucosinolates, Polyphenols and Selenocompounds
Ann. Bot., June 1, 2005; 95(7): 1075 - 1096.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
P. W. Laird
Cancer epigenetics
Hum. Mol. Genet., April 15, 2005; 14(suppl_1): R65 - R76.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
X.-c. Xu, J. J. Lee, T.-T. Wu, A. Hoque, J. A. Ajani, and S. M. Lippman
Increased Retinoic Acid Receptor-{beta}4 Correlates In vivo with Reduced Retinoic Acid Receptor-{beta}2 in Esophageal Squamous Cell Carcinoma
Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 826 - 829.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Shimizu, A. Deguchi, J. T.E. Lim, H. Moriwaki, L. Kopelovich, and I. B. Weinstein
(-)-Epigallocatechin Gallate and Polyphenon E Inhibit Growth and Activation of the Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor-2 Signaling Pathways in Human Colon Cancer Cells
Clin. Cancer Res., April 1, 2005; 11(7): 2735 - 2746.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Q.-Y. Lu, Y.-S. Jin, A. Pantuck, Z.-F. Zhang, D. Heber, A. Belldegrun, M. Brooks, R. Figlin, and J. Rao
Green Tea Extract Modulates Actin Remodeling via Rho Activity in an In vitro Multistep Carcinogenic Model
Clin. Cancer Res., February 15, 2005; 11(4): 1675 - 1683.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
L.-C. Li, P. R. Carroll, and R. Dahiya
Epigenetic Changes in Prostate Cancer: Implication for Diagnosis and Treatment
J Natl Cancer Inst, January 19, 2005; 97(2): 103 - 115.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Matsubayashi, N. Sato, K. Brune, A. L. Blackford, R. H. Hruban, M. Canto, C. J. Yeo, and M. Goggins
Age- and Disease-Related Methylation of Multiple Genes in Nonneoplastic Duodenum and in Duodenal Juice
Clin. Cancer Res., January 15, 2005; 11(2): 573 - 583.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
Y. Yuasa, H. Nagasaki, Y. Akiyama, H. Sakai, T. Nakajima, Y. Ohkura, T. Takizawa, M. Koike, M. Tani, T. Iwai, et al.
Relationship between CDX2 gene methylation and dietary factors in gastric cancer patients
Carcinogenesis, January 1, 2005; 26(1): 193 - 200.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Chen, M. Cho, K. Karlsberg, D. Zhou, and Y.-C. Yuan
Biochemical and Biological Characterization of a Novel Anti-aromatase Coumarin Derivative
J. Biol. Chem., November 12, 2004; 279(46): 48071 - 48078.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
C. D. Davis and E. O. Uthus
DNA Methylation, Cancer Susceptibility, and Nutrient Interactions
Experimental Biology and Medicine, November 1, 2004; 229(10): 988 - 995.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. Lotan and Y. Lotan
Retinoic Acid Receptor {beta}2 Hypermethylation: Implications for Prostate Cancer Detection, Prevention, and Therapy
Clin. Cancer Res., June 15, 2004; 10(12): 3935 - 3936.
[Full Text] [PDF]

Home page
 ASH Education BookHome page
A. F. List, J. Vardiman, J.-P. J. Issa, and T. M. DeWitte
Myelodysplastic Syndromes
Hematology, January 1, 2004; 2004(1): 297 - 317.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.